Class III alcohol dehydrogenase (ADH3), also termed formaldehyde dehydrogenase or S-nitrosoglutathione reductase, plays a critical role in the enzymatic oxidation of formaldehyde and reduction of nitrosothiols that regulate bronchial tone. Considering reported associations between formaldehyde vapor exposure and childhood asthma risk, and thus potential involvement of ADH3, we reviewed the ontogeny, distribution, and regulation of mammalian ADH3. Recent studies indicate that multiple biological and chemical stimuli influence expression and activity of ADH3, including the feedback regulation of nitrosothiol metabolism. The levels of ADH3 correlate with, and potentially influence, bronchial tone; however, data gaps remain with respect to the expression of ADH3 during postnatal and early childhood development. Consideration of ADH3 function relative to the respiratory effects of formaldehyde, as well as to other chemical and biological exposures that might act in an additive or synergistic manner with formaldehyde, might be critical to gain better insight into the association between formaldehyde exposure and childhood asthma.
Formaldehyde has recently been suggested to represent a new class of indoor chemicals that pose as risk factors for respiratory and allergic effects that are distinct from other compounds (Mendell, 2007) . The majority of this evidence arises from literature focusing on children (Krakowiak et al., 1998; Garrett et al., 1999; Franklin et al., 2000; Rumchev et al., 2002; Mendell, 2007) . The disposition of drugs and environmental toxicants can be substantially different among adults and children and may alter susceptibility to adverse health effects (Ginsberg et al., 2002 (Ginsberg et al., , 2007 Hattis et al., 2003; de Zwart et al., 2004; Barton, 2005; Makris et al., 2008) . Indeed, formaldehyde is an example of a chemical that appears to be well metabolized in adults, but less is known about formaldehyde disposition in children. Recent efforts to understand differential susceptibility between adults and children have focused on physiological parameters (e.g., ventilation rate) and the ontogeny of enzymes that likely influence chemical disposition (Clewell et al., 2002; Hines and McCarver, 2002; McCarver and Hines, 2002; Benedetti et al., 2007; de Zwart et al., 2008; Dewoskin and Thompson, 2008; Hines, 2008) . Although such efforts have rightly included the class I alcohol dehydrogenase (ADH1) responsible for ethanol clearance, comparatively little attention has been given to the class III isoform (ADH3) responsible for formaldehyde metabolism. This response may be due, in part, to the fact that ADH3 was long considered a ubiquitous housekeeping gene and has only recently been discovered to play an important role in multiple metabolic pathways with potentially far reaching consequences for cell physiology (Holmquist and Vallee, 1991; Hur and Edenberg, 1992; Deltour et al., 1999; Molotkov et al., 2002; Hoog et al., 2003; Liu et al., 2004) . In particular, ADH3 reduction of the endogenous bronchodilator S-nitrosoglutathione (GSNO) has a profound influence on pulmonary physiology, which is underscored by reports that polymorphisms in this highly conserved gene can alter asthma risk in children (Edenberg et al., 1995; Liu et al., 2001; Henderson and Gaston, 2005; Que et al., 2005; Wu et al., 2007; Moore et al., 2009 ). We have previously described how ADH3 enzyme activity may influence pulmonary physiology and responses to formaldehyde (Thompson and Grafstrom, 2008; . In this study, we further review the distribution, ontogeny, and regulation of ADH3 in humans and laboratory animals to better characterize how ADH3 may interact with environmental exposures to influence pulmonary physiology and perhaps life stage susceptibility to asthma.
Functions of Mammalian ADH3. ADH3 has been evolutionarily conserved from bacteria to vertebrates, and it is the evolutionary precursor to the ADH family (Danielsson and Jornvall, 1992; Hoog et al., 2001; Liu et al., 2001; Canestro et al., 2003) . Gene duplication and mutation in the active site gave rise to gene members that lost the ability to metabolize formaldehyde, but gained activity toward short chain alcohols such as ethanol (Engeland et al., 1993) . As shown in Fig. 1, ADH3 catalyzes the NAD ϩ -dependent oxidation of formalde-hyde once it has bound to GSH to form S-hydroxymethylglutathione (HMGSH), and it has thus been called GSH-dependent formaldehyde dehydrogenase (Uotila and Koivusalo, 1974; Koivusalo et al., 1989) . Likewise, ADH3 is also referred to as GSNO reductase because it catalyzes the NADH-dependent reduction of GSNO, which is a GSH conjugate of nitric oxide (NO) (Jensen et al., 1998; Liu et al., 2001; Hedberg et al., 2003; Staab et al., 2008) . The significant activity and importance of ADH3 in the metabolism of these two substrates have been demonstrated through enzymatic analyses as well as through gene deletion (Uotila and Koivusalo, 1974; Koivusalo et al., 1989; Jensen et al., 1998; Deltour et al., 1999; Liu et al., 2001 Liu et al., , 2004 Teng et al., 2001; Hedberg et al., 2003; Que et al., 2005; Staab et al., 2008) . Purified ADH3 exhibits minimal enzymatic activity toward retinol, yet knockout studies indicate that the overall ubiquitous expression of ADH3 contributes significantly to retinoic acid production (Molotkov et al., 2002) . In contrast to formaldehyde and GSNO, the significance of ADH3-mediated retinol metabolism in humans remains less characterized. ADH3 has received renewed attention over the past decade because GSNO represents a cGMP-independent NO signaling pathway that regulates a broad spectrum of cellular proteins and functions via S-nitrosylation of protein cysteine residues (Hess et al., 2005; Foster et al., 2009 ). This process includes G protein-coupled receptor modulation, host and viral transcription factor regulation, and p53 degradation (Mannick et al., 1994 (Mannick et al., , 1999 Schonhoff et al., 2002; Marshall et al., 2004; D'Agostino et al., 2005; Hess et al., 2005; Kokkola et al., 2005; Wang et al., 2005; Whalen et al., 2007) . Dysregulation of nitrosothiol signaling is also implicated in diseases of the central nervous system, cardiovascular system, and lung (Henderson and Gaston, 2005; Gaston et al., 2006; Pannu and Singh, 2006; Schonhoff et al., 2006; Wu et al., 2007; Lima et al., 2009a; Moore et al., 2009 ). The derangement of nitrosothiol homeostasis in response to formaldehyde has been suggested and demonstrated experimentally (Yi et al., 2007; Staab et al., 2008 Staab et al., , 2009 Thompson and Grafstrom, 2008; . It is clear that the distribution, ontogeny, and regulation of ADH3 have important implications for the clearance of endogenous and exogenous formaldehyde, as well as the regulation and modulation of NO signaling pathways.
Distribution and Ontogeny of Mammalian ADH3. ADH3 is present in all adult human and rodent tissues, as well as the placenta and fetal brain, lung, liver, and kidney (Uotila and Koivusalo, 1974; Pares et al., 1984; Dafeldecker and Vallee, 1986; Keller et al., 1990; Estonius et al., 1996; Cheung et al., 1999 Cheung et al., , 2003 Maly et al., 2001) . ADH3 also appears to be the only ADH family member expressed in human and rodent brain tissue (Beisswenger et al., 1985; Giri et al., 1989; Estonius et al., 1996; Galter et al., 2003) . The distribution pattern within the brain is similar in rodents and humans, including expression in the cortex, hippocampus, midbrain (e.g., substantia nigra), and cerebellum (Galter et al., 2003) . In terms of subcellular distribution, ADH3 localizes to the cytoplasm and the nucleus of several cell types and may associate with chromatin (Keller et al., 1990; Iborra et al., 1992; Fernandez et al., 2003) . In human oral mucosa, ADH3 mRNA levels distinctly localize to the basal layer with progressively less expression toward the surface (Hedberg et al., 2000) . In contrast, ADH3 immunoreactivity is more evenly distributed albeit with a slight increase just below the outmost keratinized FIG. 1. Three major metabolic activities of ADH3. Glutathione (GSH)-dependent oxidation of formaldehyde (top reaction) was the first major metabolic pathway ascribed to ADH3. More recently, ADH3 has been shown to efficiently catalyze the NADH-dependent reduction of GSNO (middle reaction). ADH3 also has a very limited capacity to metabolize all-trans-retinol (bottom reaction), but given its overall ubiquitous expression, it has been suggested to significantly contribute to retinoic acid production. (Chemical structures were obtained from ChemACX.com.) layer (Hedberg et al., 2000) . Consistent with its high expression in the basal epithelium, ADH3 mRNA levels tend to be higher in proliferating cells both in vitro and in vivo (Nilsson et al., 2004) . It is interesting to note that ADH3 mRNA exhibits the same distribution pattern as the immunostaining of the single NO synthase (NOS) isoform in the prevertebrate amphioxus (Godoy et al., 2006) . This effect is consistent with the role of ADH3 in nitrosothiol signaling, and it might explain the wider distribution pattern of ADH3 in vertebrates, where multiple NOS isoforms have evolved and are widely distributed. Furthermore, the N terminus of neuronal NOS has a PDZ domain, which allows proteins involved in signal transduction pathways to localize and interact with one another (Zhou and Zhu, 2009 ). The C terminus of ADH3 is reported to bind to a peptide probe comprised of the PDZ domain of syntropin (Hoffmuller et al., 1999) . These findings suggests that NOS and ADH3 might physically interact with one another.
The ontogeny of ADH3 in humans and rodents is summarized in Tables 1-3 . In humans, ADH3 transcripts have been detected in fetal lung, liver, brain, and kidney (Estonius et al., 1996; Hines and McCarver, 2002) . Unfortunately, there do not appear to be data to assess how ADH3 expression and activity matures relative to adult humans. This poses a critical data gap because pharmacokinetic analyses suggest that lung absorption of particles and reactive gases (e.g., formaldehyde) is higher in neonates and children, and that many enzyme systems are initially immature in infants but can then exceed adult levels (on a per kilogram basis) for brief periods during mid childhood (Clewell et al., 2002; Ginsberg et al., 2002 Ginsberg et al., , 2007 Hattis et al., 2003) . These pharmacokinetic properties imply that, relative to adults, formaldehyde absorption is probably higher in children and that there are stages in development where ADH3 activity will be concomitantly lower in very young children. Considering also that ADH3 expression correlates with proliferation, that lungs grow and develop postnatally, and that the mRNA and activity of some enzymes can peak and decline before adulthood, it is possible that ADH3 activity is higher in some children than adults (Pinkerton and Joad, 2000; Nilsson et al., 2004; de Zwart et al., 2008) .
In mice, ADH3 mRNA has been detected in whole embryos at the earliest stages of development analyzed, i.e., 6.5 days postconception (dpc) (Ang et al., 1996; Westerlund et al., 2005) . More specifically, ADH3 mRNA was detected at embryonic day 13.5 in the brain, liver, adrenal gland, and the conjunctival, olfactory, and intestinal epithelia (Westerlund et al., 2005) . ADH3 enzymatic activity toward formaldehyde (300 -400 pmol/min/mg) has been detected in the earliest stages of development examined, i.e., in the 8 to 10 somite range, or approximately 8.5 dpc (Harris et al., 2003) . This activity increased approximately 2-fold to 550 pmol/min/mg by 9.5 dpc. At approximately 8.5 dpc, a comparison of ADH3 activity in the head, heart, and trunk revealed that the activity was approximately 400, 75, and 350 pmol/min/mg, respectively. By 9.5 dpc, the activity in all three regions was approximately 550 pmol/min/mg (Harris et al., 2003) . As in humans, there does not appear to be specific data for how rapidly ADH3 expression and activity reach adult levels in mice.
In rats, ADH3 mRNA was also detected in the brain, liver, adrenal gland, and in the conjunctival, olfactory, and intestinal epithelia at the earliest time points examined, i.e., embryonic day 12.5 (Westerlund et al., 2005) . ADH3 enzymatic activity was also found prenatally at the earliest somite ranges investigated, and it increased from 525 to 550 pmol/min/mg prenatally (Harris et al., 2003) . Overall, embryonic ADH3 activity appeared more rapidly in rats compared with mice, but activity in both species achieved similar levels before parturition. As in the mouse, ADH3 activity was lowest in the heart at the earlier stages of development (ϳ200 pmol/min/mg) but was equivalent to the activity in the head and trunk at later somite stages (Harris et al., 2003) . Fetal ADH3 enzymatic activity toward octanol was also reported in several tissues (brain, liver, stomach, eye) as early as 15 dpc; postnatally, ADH3 activity in brain tissue was approximately 40% of adult levels at birth and was roughly equivalent to a 70-day-old rat by approximately day 40 . It is interesting to note that maternal exposure to ethanol during gestation and nursing significantly reduced liver ADH1 in the offspring by approximately 70%, whereas brain ADH3 activity was increased approximately 30% .
Regulation of Mammalian ADH3. Sequence comparisons of the coding regions of both ADH3 and ADH1 between mice and humans indicate a high degree of conservation-93 and 83%, respectively (Edenberg et al., 1995) . In contrast, the promoter region of ADH3 is far less conserved across species than is the promoter region of ADH1 (Edenberg et al., 1995) . This result suggests that although the function of ADH3 is very important, its regulation may be quite different across species. The 5Ј-untranslated region of human ADH3 shares little homology with other human ADH classes, and unlike other ADH family members, the 5Ј region of both human and rodent ADH3 lacks a TATA box and contains many CpG doublets (Hur and Edenberg, 1992) . Although these are typical characteristics of housekeeping genes, human ADH3 mRNA also contains two weak 5Ј translation start sites upstream of the ADH3 open reading frame; this structure is more characteristic of genes with regulatory function such as growth factors, transcription factors, and genes involved in signal transduction (Hur and Edenberg, 1992; Kwon et al., 2001 ). Site-directed mutations to silence these 5Ј start codons significantly increase ADH3 expression in human cell lines (Table 4 ), suggesting that these upstream open reading frames (uORFs) may play a role in the regulation of ADH3 (Kwon et al., 2001) . In this regard, uORFS are known to regulate protein translation, and mutations that create or delete such sites are associated with certain diseases (Chatterjee and Pal, 2009 
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Mutational studies indicate that there are at least two 5Ј Sp1 binding sites flanking the transcription start site (Ϫ20 and ϩ10) that significantly affect ADH3 expression (Kwon et al., 1999) . In fact, a polymorphism identified in one of these regions significantly decreases ADH3 expression in vitro . Studies suggest that ADH3 expression is highest when Sp1 occupies both of these 5Ј binding sites, but that Sp3 and Sp4 both repress ADH3 expression by competing for these same sequences (Kwon et al., 1999) . Physiological concentrations of GSNO increase the binding of Sp1 and Sp3 to consensus oligonucleotides, whereas higher levels of GSNO can decrease Sp3 binding in favor of Sp1 (Zaman et al., 2004) . Considering that Sp3 activates some genes and represses others (Suske, 1999) , the affects of GSNO on transcription are likely to be gene specific. Because Sp3 clearly represses ADH3 expression (Kwon et al., 1999) , elevated GSNO levels should favor Sp1 binding and ADH3 transcription and serve as a regulatory feedback to reduce GSNO. On the other hand, too much ADH3 activity may favor Sp3 binding and reduce ADH3 expression. Table 4 summarizes the transcriptional and translational regulatory control elements that have been experimentally demonstrated to influence ADH3 mRNA and protein expression. In addition to transcriptional and translational regulation of ADH3, the activity of ADH3 can be influenced by cellular redox status. The NAD ϩ /NADH ratio normally favors oxidation reactions; however, such reactions can decrease this ratio as has been shown during ethanol consumption (Smith and Newman, 1959) . Furthermore, oxidation and reduction reactions carried out by ADH isozymes can be accelerated in the presence of certain substrate pairs (e.g., GSNO and HMGSH) (see Fig. 1 ) because the coenzyme remains bound to the protein (Cronholm, 1987; Staab et al., 2008) . There is also evidence that high GSH concentrations can decrease GSNO turnover as well as shift the product formation of GSNO reduction from GSH sulfinamide (GSONH 2 ) to GSH disulfide and hydroxylamine (Staab et al., 2008) . Under low GSH conditions, GSNO reduction is accelerated along with the formation of GSONH 2 , which is an inhibitor of glutathione S-transferase (Staab et al., 2008) . This inhibition may function to conserve GSH. It is clear that the regulation of ADH3 at the protein, mRNA, and transcriptional level may have profound implications for nitrosative and oxidative status. ADH3 Influences Pulmonary Physiology. Clinical and laboratory research indicate that airway inflammation and hyperresponsivity are related but perhaps uncoupled processes. For instance, child asthmatics exhibit paradoxical low levels of nitrosothiols in airways despite high levels of NO in exhaled breath (Kharitonov et al., 1994; Gaston et al., 1998) . In murine allergy models, wild-type and ADH3 null mice exhibit similar signs of antigen-induced inflammation, yet ADH3 null mice are protected from hyperresponsivity (Que et al., 2005) . The a, assumed but not demonstrated between 2 time points; DPC, days postconception; ϩ, present. * ADH3 activity was assessed by formaldehyde metabolism (pmol/min/mg) and estimated from plots in reference (Harris et al., 2003) . Activity data was originally expressed as somite ranges. The data in mice were matched to DPC in The Edinburgh Mouse Atlas. It should be noted that the development stages differ slightly by mouse strain and the stages in this table are estimations only.
TABLE 3
Ontogeny of ADH3 in rats Data sources: Boleda et al., 1992; Harris et al., 2003; Westerlund et al., 2005 a, assumed but not demonstrated between 2 time points; DPC, days postconception; PND, postnatal day; P0, parturition; ϩ, present. * ADH3 activity was assessed by formaldehyde metabolism (pmol/min/mg) and estimates from plots in reference (Harris et al., 2003) . Activity data was originally expressed as somite ranges; no attempt was made to match with DPC. **ADH3 activity was assessed by octanol metabolism (units/g) and estimated from plots in . Tsp, transcriptional start point; AUG, translational start codon; CUG, mutated start codon; Sp, specificity protein transcription factor. a The top row reflects the two weak translational start sites upstream of the ADH3 open reading frame (ORF). The lower rows reflect site-directed mutations in these uORFs. b A polymorphism in this region has also been shown to decrease ADH3 expression in vitro ).
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at ASPET Journals on June 25, 2017 dmd.aspetjournals.org hyperresponsivity exhibited by the wild-type mice correlates with inflammatory responses that increase ADH3 expression and nitrosothiol depletion in airways, which obviously cannot occur in ADH3 null mice (Que et al., 2005) . Dysregulation of nitrosothiol signaling and altered ADH3 activity are also implicated in human asthma, because exogenous GSNO alleviates bronchoconstriction and ADH3 polymorphisms are associated with altered asthma risk in children (Snyder et al., 2002; Wu et al., 2007; Moore et al., 2009 ). More recently, ADH3 expression and activity levels were shown to be significantly higher in adult asthmatics than nonasthmatics (Que et al., 2009) . Formaldehyde exposure induces similar pathological responses as those observed in allergen studies, including thickening and eosinophilia in rodent lungs as well as increases in ADH3 mRNA and GSNO breakdown (Jung et al., 2007; Yi et al., 2007) . As an ADH3 substrate, formaldehyde can also accelerate ADH3-mediated GSNO reduction via NAD ϩ /NADH cofactor recycling (Staab et al., 2008 (Staab et al., , 2009 . These data indicate that formaldehyde, like antigens, can increase ADH3 expression and activity in airways and thus influence pulmonary physiology by altering nitrosothiol levels (Thompson and Grafstrom, 2008; . To date, controlled human studies have not examined whether formaldehyde alters ADH3 or nitrosothiol homeostasis. However, two recent studies have examined the influence of formaldehyde on response to allergens, with one study reporting that formaldehyde potentiates bronchoresponsiveness and the other indicating that formaldehyde mitigates bronchoconstriction (Casset et al., 2006; Ezratty et al., 2007) . Given that pulmonary responses are probably influenced by underlying conditions that influence nitrosothiol status as well as exposure-induced changes in nitrosothiol homeostasis, the effects of formaldehyde on pulmonary endpoints may be highly labile and thus sensitive to dose, duration, and timing of measurements.
Potential Implications for Childhood Asthma. The incidence of childhood asthma continues to increase in the industrialized world (Dietert and Zelikoff, 2008) . Most childhood asthma begins in infancy, yet a large percentage of children appear to "outgrow" the disease (Koh and Irving, 2007) . This finding may suggest that there are developmental windows of susceptibility to symptoms such as wheezing that may ultimately resolve due do maturation, or that asthma symptoms mitigate due to the multifactorial nature of the disease. There are several genes involved in nitrosothiol homeostasis, numerous inflammatory cells and molecules involved in response to allergens, and a vast array of biochemical and genetic factors that contribute to asthma (Barnes et al., 1998; Barnes, 2008; Bateman et al., 2008; Foster et al., 2009; Lima et al., 2009b) . Moreover, there are prenatal and early postnatal immunological changes that may influence the development of allergic diseases and asthma specifically (Dietert and Zelikoff, 2008) . However, as we have described, ADH3 expression is tightly linked to immune responses and cell proliferation, and it is responsive to biological and chemical stimuli. This effects suggests that formaldehyde exposure may act additively or synergistically with other environmental exposures to adversely affect pulmonary function. Given that a single adverse event such as respiratory distress may have significant health consequences, the influence of environmental exposures on ADH3 and nitrosothiol levels deserves further investigation.
Conclusion
The dual role of ADH3 in formaldehyde metabolism and nitrosothiol regulation lends mechanistic plausibility to reported associations between formaldehyde exposure and adverse respiratory effects. Genetic studies continue to demonstrate an important role for this enzyme in a wide array of diseases and health conditions, as well as the potential for interindividual variability and susceptibility due to complex transcriptional and translational regulation. Considering the roles of ADH3 in metabolism of a reactive aldehyde, a NO signaling molecule, and a retinoic acid precursor, relatively little is known about its ontogeny and regulation in mammals and, in particular, humans. Moreover, the potential for these substrates to influence the disposition of one another, coupled with broader ontological aspects of pharmacokinetics, make this an intriguing enzyme for future research.
